North American Report

Nausea Medicine Market Is Anticipated to Have a Lucrative CAGR of 7.2% by 2023

Nausea Medicine Market Is Anticipated to Have a Lucrative CAGR of 7.2% by 2023

Nausea Medicine Market
Market Research Future published a research report on “Nausea Medicine Market Research Report- Global forecast till 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

 

Nausea Medicine Market Analysis: By Mode of Administration (IV, Tablets), By Type (Antacids, Antagonists), Indication (GERD, Chemotherapy), Indication (Gastroenteritis, Gastric Ulcer), End User (Hospitals, Clinics, Pharmaceutical Companies) – Global Forecast till 2023

Market Synopsis of the Global Nausea Medicine Market

The Global Nausea Medicine Market is expected to grow at a CAGR of 7.2% during the forecast period.

Nausea is a state of stomach distress with an urge to vomit. Common indications of nausea are motion sickness, seasickness, medication and chemotherapy. Stomach ulcers can also cause nausea. Medications and proper dietary habits can treat nausea.

Rising prevalence of gastrointestinal diseases, such as Gastroesophageal Reflux Disease (GERD), and viral gastroenteritis, and availability of a wide range of treatment options drive the market growth. Furthermore, changing lifestyle and dietary habits also influence the market.

 

Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/4523

 

Key Players in the Global Nausea Medicine Market     

Some of the key players in this market are Merck & Co., Inc. (U.S.), Sanofi (France), TESARO, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer (U.S.), GlaxoSmithKline (U.S.), ANI Pharmaceuticals, Inc. (U.S.)

 

Segments                                                                                                                                            

The global nausea medicine market is segmented on the basis of type, mode of administration, indication and end user.

On the basis of type, market is segmented into antacids, antagonists, anti-anxiety drugs, steroids, Cannabinoids and Others.

Antacids are further segmented into serotonin (5-HT3) antagonists, NK-1 antagonists and dopamine antagonists.

On the basis of mode of administration, the market is segmented into IVs, tablets and others.

On the basis of indication, the market is segmented into gastroesophageal reflux disease (GERD), viral gastroenteritis, motion sickness and seasickness, medication, chemotherapy and others.

On the basis of end user, the market is segmented into hospitals, clinics, pharmaceutical companies and others.

 

Regional Analysis of the Global Nausea Medicine Market                    

America is the largest market for nausea medicine owing to rising prevalence of gastrointestinal diseases such as GERD drive the market. Furthermore, according to an article published in the “The Journal of Pediatrics” the prevalence of nausea is founding to be increasing among school going children. It also stated the Functional Gastrointestinal Disorders (FGIDs) are frequently associated with nausea. Prevalence of viral gastroenteritis is found to be increasing in the U.S., especially among the pediatric population. According to the Center for Disease Control and Prevention (CDC), each year in the United States, there are nearly 19 to 21 million cases of acute gastroenteritis. Furthermore the prevalence of acute gastrointestinal diseases is found to be high in Canada.

Europe is the second largest market for nausea medicine which exhibits growth opportunities owing to the high prevalence of nausea and vomiting among pregnant women whose population is found to be increasing. Furthermore, there is an extensive demand for the diagnosis and treatment of nausea, especially among pregnant women which will influence the market growth in Europe. Additionally, prevalence of chemotherapy induced nausea is found to be increasing steadily in many parts for the Europe in the last few years. This will further increase the demand for nausea medicine in Europe.

In Asia Pacific, the market is expected grow at the fastest rate owing to changing lifestyle and increasing geriatric population fuel the market growth. Furthermore, viral gastritis and gastric ulcer are found to be prevalent among the Asian Population.  However, presence of misbranded and spurious drugs may restrain the market growth in Asia Pacific.

The Middle East & Africa also show a steady rise in the market owing to rising prevalence of chemotherapy induced nausea.

 

Get Discount @ https://www.marketresearchfuture.com/check-discount/4523

 

LIST OF FIGURES

Figure 1    Research Process

Figure 2    Segmentation for Global Nausea Medicine Market

Figure 3    Segmentation Market Dynamics for Nausea Medicine Market

Figure 4    Global Nausea Medicine Market Share, by Mode of Administration 2016

Figure 5    Global Nausea Medicine Market Share, by Indication 2016

Figure 6    Global Nausea Medicine Market Share, by End Users, 2016

Figure 7    Global Nausea Medicine Market Share, by Region, 2016

Figure 8    North America Nausea Medicine Market Share, by Country, 2016

Figure 9    Europe Nausea Medicine Market Share, by Country, 2016

Figure 10    Asia Pacific Nausea Medicine Market Share, by Country, 2016

Figure 11    Middle East & Africa Nausea Medicine Market Share, by Country, 2016

Figure 12    Global Nausea Medicine Market: Company Share Analysis, 2016 (%)

Figure 13    Merck & Co., Inc.: Key Financials

Figure 14    Merck & Co., Inc.: Segmental Revenue

Figure 16    Merck & Co., Inc.: Geographical Revenue

Figure 17    Sanofi: Key Financials

Figure 18    Sanofi: Segmental Revenue

Figure 19    Sanofi: Geographical Revenue

Figure 20    TESARO, Inc.: Key Financials

Figure 21    TESARO, Inc.: Segmental Revenue

Figure 22    TESARO, Inc.: Geographical Revenue

Figure 23    F. Hoffmann-La Roche Ltd: Key Financials

Figure 24    F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 25    F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 26    GlaxoSmithKline: Key Financials

Figure 27    GlaxoSmithKline: Segmental Revenue

Figure 28    GlaxoSmithKline: Geographical Revenue

Figure 29    Pfizer: Key Financials

Figure 30    Pfizer: Segmental Revenue

Figure 31    Pfizer: Geographical Revenue

Figure 32    Pfizer Inc: Key Financials

Figure 33    Pfizer Inc: Segmental Revenue

Figure 34    Pfizer Inc: Geographical Revenue

 

Continue…

We are thankful for the support and assistance from Nausea Medicine Market Research Report- Global forecast till 2023 chain related technical experts and marketing experts during Research Team survey and interviews.

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/nausea-medicine-market-4523